
The left image above shows the gene FGFR1 in its natural state. The right image shows the gene when exposed to laser light, which causes the gene to activiate and deactivate. Credit: University at Buffalo.
The advancement, made possible by tiny photonic implants, could lead to new treatments for cancer, mental disorders
It seems like everything is going wireless these days. That now includes efforts to reprogram the human genome.
A new University at Buffalo-led study describes how researchers wirelessly controlled FGFR1 — a gene that plays a key role in how humans grow from embryos to adults — in lab-grown brain tissue.
The ability to manipulate the gene, the study’s authors say, could lead to new cancer treatments, and ways to prevent and treat mental disorders such as schizophrenia.
The work — spearheaded by UB researchers Josep M. Jornet, Michal K. Stachowiak, Yongho Bae and Ewa K. Stachowiak — was reported in the June edition of the Proceedings of the Institute of Electrical and Electronics Engineers.
It represents a step forward toward genetic manipulation technology that could upend the treatment of cancer, as well as the prevention and treatment of schizophrenia and other neurological illnesses. It centers on the creation of a new subfield of research the study’s authors are calling “optogenomics,” or controlling the human genome through laser light and nanotechnology.
“The potential of optogenomic interfaces is enormous,” says co-author Josep M. Jornet, PhD, associate professor in the Department of Electrical Engineering in the UB School of Engineering and Applied Sciences. “It could drastically reduce the need for medicinal drugs and other therapies for certain illnesses. It could also change how humans interact with machines.”
From “optogenetics” to “optogenomics”
For the past 20 years, scientists have been combining optics and genetics — the field of optogenetics — with a goal of employing light to control how cells interact with each other.
By doing this, one could potentially develop new treatments for diseases by correcting the miscommunications that occur between cells. While promising, this research does not directly address malfunctions in genetic blueprints that guide human growth and underlie many diseases.
The new research begins to tackle this issue because FGFR1 — it stands for Fibroblast Growth Factor Receptor 1 — holds sway over roughly 4,500 other genes, about one-fifth of the human genome, as estimated by the Human Genome Project, says study co-author Michal K. Stachowiak.
“In some respects, it’s like a boss gene,” says Stachowiak, PhD, professor in the Department of Pathology and Anatomical Sciences in the Jacobs School of Medicine and Biomedical Sciences at UB. “By controlling FGFR1, one can theoretically prevent widespread gene dysregulations in schizophrenia or in breast cancer and other types of cancer.”
Light-activated toggle switches
The research team was able to manipulate FGFR1 by creating tiny photonic brain implants. These wireless devices include nano-lasers and nano-antennas and, in the future, nano-detectors.
Researchers inserted the implants into the brain tissue, which was grown from induced pluripotent stem cells and enhanced with light-activated molecular toggle switches. They then triggered different laser lights — common blue laser, red laser and far-red laser — onto the tissue.
The interaction allowed researchers to activate and deactivate FGFR1 and its associated cellular functions — essentially hacking the gene. The work may eventually enable doctors to manipulate patients’ genomic structure, providing a way to prevent and correct gene abnormalities, says Stachowiak, who also holds an appointment in UB’s Department of Biomedical Engineering, a joint program between the Jacobs School and UB’s engineering school.
Next steps
The development is far from entering the doctor’s office or hospital, but the research team is excited about next steps, which include testing in 3D “mini-brains” and cancerous tissue.
Learn more: Researchers wirelessly hack ‘boss’ gene, a step toward reprogramming the human genome
The Latest on: Reprogramming the human genome
via Google News
The Latest on: Reprogramming the human genome
- Reversing The Aging Clock With Epigenetic Reprogrammingon January 13, 2021 at 11:46 am
As aging researchers are aware, “birthday candles are not a good guide” to either human health or longevity. But there is an abundance of clues in the genome and, as suggested by studies in animals, ...
- The QAnon Doctor Pushing Wild Conspiracies About the COVID Vaccineon January 8, 2021 at 10:11 am
Dr. Carrie Madej spoke at the Capitol riots Wednesday and called the COVID vaccine a "witches' brew." Want the best of VICE News straight to your inbox? When Dr. Carrie Madej took the stage at the ...
- Pluripotency and Disease Modelingon January 7, 2021 at 4:00 pm
Otonkoski lab is interested in nuclear reprogramming and genome editing ... Diego Balboa defended his doctoral dissertation with the title "Human Pluripotent Stem Cells and CRISPR-Cas9 Genome Editing ...
- Epigenetic Reprogramming in Canceron January 1, 2021 at 4:00 pm
These and other studies thus document widespread roles for CRs in human cancer, complementing similarly ... TFs and CRs unveiled by mechanistic studies and cancer genome sequencing. The analogy to ...
- New, High-Throughput Mitochondria Transfer Device Developedon January 1, 2021 at 1:20 pm
"What sets MitoPunch apart from other technologies is an ability to engineer non-immortal, non-malignant cells, such as human skin cells, to generate unique mitochondrial DNA-nuclear genome ...
- UCLA scientists develop high-throughput mitochondria transfer deviceon December 29, 2020 at 8:13 am
"What sets MitoPunch apart from other technologies is an ability to engineer non-immortal, non-malignant cells, such as human skin cells, to generate unique mitochondrial DNA-nuclear genome ...
- The virus-free scientific breakthroughs of 2020, chosen by scientistson December 20, 2020 at 1:48 pm
As Crispr-based methods do not leave scars or extraneous genetic material in the plant genome ... human diseases. For instance, 2020 has seen the first clinical trials for Crispr-based ...
- Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogrammingon December 12, 2020 at 4:00 pm
Cells lacking the activity of the ISG15-specific protease USP18 exhibit increased resistance to clinically relevant CV strains, therefore suggesting that stabilizing ISGylation by inhibiting USP18 ...
- Researchers wirelessly manipulate gene, step toward reprogramming the human genomeon August 2, 2019 at 12:19 pm
Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.
- Human oocytes reprogram somatic cells to a pluripotent stateon December 18, 2017 at 6:55 am
Until now, it has not been possible to achieve reprogramming of a somatic cell nucleus ... now report the successful derivation of triploid human pluripotent stem-cell lines through somatic genome ...
via Bing News